Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Malignant Lymphoma

  Free Subscription


08.05.2023

4 Blood
1 Br J Haematol
1 Discov Oncol
1 Eur J Haematol
2 Haematologica
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
2 Leuk Lymphoma
3 Leukemia
3 N Engl J Med
1 Neurology
1 Oncogene
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Blood

  1. BIGENWALD C, Zitvogel L
    Light shed from the gut in large B-cell lymphoma.
    Blood. 2023;141:2165-2166.
    PubMed        

  2. BARTA SK
    Is it prime time for T-cell lymphoma?
    Blood. 2023;141:2161-2163.
    PubMed        

  3. ZINZANI PLL, Thieblemont C, Melnichenko V, Bouabdallah K, et al
    Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma: Final Analysis of KEYNOTE-170.
    Blood. 2023 May 2:blood.2022019340. doi: 10.1182/blood.2022019340.
    PubMed         Abstract available

  4. TOLU SS, Amengual JE
    Queen's gambit: response-adapted win in CAYA with cHL.
    Blood. 2023;141:2037-2038.
    PubMed        


    Br J Haematol

  5. WEI C, Wang W, Zhang Y, Zhao D, et al
    Mutation profiling, tumour burden assessment, outcome prediction and disease monitoring by circulating tumour DNA in peripheral T-cell lymphoma.
    Br J Haematol. 2023 May 3. doi: 10.1111/bjh.18824.
    PubMed         Abstract available


    Discov Oncol

  6. ZHAN Z, Guo W, Li J, Wan X, et al
    Clinical features and prognosis of double primary malignant neoplasms in patients with non-hodgkin lymphoma.
    Discov Oncol. 2023;14:54.
    PubMed         Abstract available


    Eur J Haematol

  7. WANG Y, Li J, Xue TL, Tian S, et al
    Clinical, biological and outcome features of P2RY8-CRLF2 and CRLF2 over-expression in pediatric B-cell precursor acute lymphoblastic leukemia according to the CCLG-ALL 2008 and 2018 protocol.
    Eur J Haematol. 2023 Feb 22. doi: 10.1111/ejh.13948.
    PubMed         Abstract available


    Haematologica

  8. THURNER L, Fadle N, Regitz E, Roth S, et al
    B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma.
    Haematologica. 2023 May 4. doi: 10.3324/haematol.2023.282698.
    PubMed         Abstract available

  9. BARZ MJ, Behrmann L, Capron D, Zuchtriegel G, et al
    B- and T-cell acute lymphoblastic leukemias evade chemotherapy at distinct sites in the bone marrow.
    Haematologica. 2023;108:1244-1258.
    PubMed         Abstract available


    Int J Cancer

  10. ENTROP JP, Weibull CE, Smedby KE, Jakobsen LH, et al
    Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study.
    Int J Cancer. 2023 Apr 29. doi: 10.1002/ijc.34552.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  11. VEGA RBM, Harker-Murray PD, Forlenza CJ, Cole P, et al
    Radiotherapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group.
    Int J Radiat Oncol Biol Phys. 2023 Apr 26:S0360-3016(23)00381.
    PubMed         Abstract available


    Leuk Lymphoma

  12. CASTRO D, Valcarcel B, Runciman T, Huerta-Collado Y, et al
    The prognostic role of red cell distribution width on all-cause and cause-specific outcomes in peripheral T-cell lymphoma: a retrospective cohort study.
    Leuk Lymphoma. 2023 May 3:1-9. doi: 10.1080/10428194.2023.2205975.
    PubMed         Abstract available

  13. GULBRANDSEN MS, Noding AS, Smeland KB, Eikeland SA, et al
    Health-related quality of life, depressive symptoms, and chronic fatigue in long-term survivors of Hodgkin lymphoma.
    Leuk Lymphoma. 2023 May 5:1-12. doi: 10.1080/10428194.2023.2198053.
    PubMed         Abstract available


    Leukemia

  14. PASTORET C, Llamas-Gutierrez F, Fouchard M, Moignet A, et al
    Molecular mechanisms underlying transformation of large granular lymphocytic leukemia to high-grade T-cell lymphoma.
    Leukemia. 2023 May 4. doi: 10.1038/s41375-023-01922.
    PubMed        

  15. XIA Y, Sun T, Li G, Li M, et al
    Spatial single cell analysis of tumor microenvironment remodeling pattern in primary central nervous system lymphoma.
    Leukemia. 2023 Apr 29. doi: 10.1038/s41375-023-01908.
    PubMed         Abstract available

  16. ANAGNOSTOU T, Yang ZZ, Jalali S, Kim HJ, et al
    Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma.
    Leukemia. 2023 Apr 28. doi: 10.1038/s41375-023-01911.
    PubMed         Abstract available


    N Engl J Med

  17. BROWN JR, Cohen A, Shadman M
    Zanubrutinib in Chronic Lymphocytic Leukemia. Reply.
    N Engl J Med. 2023;388:1720-1721.
    PubMed        

  18. LIANG Y, Gale RP
    Zanubrutinib in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2023;388:1720.
    PubMed        

  19. BYRD JC, Rothbaum W
    Zanubrutinib in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2023;388:1719-1720.
    PubMed        


    Neurology


  20. Reader Response: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy.
    Neurology. 2023 May 3:10.1212/WNL.0000000000207470.
    PubMed        


    Oncogene

  21. ZHENG J, Wang Z, Pan X, Zhang Z, et al
    DNMT3A(R882H) accelerates angioimmunoblastic T-cell lymphoma in mice.
    Oncogene. 2023 May 1. doi: 10.1038/s41388-023-02699.
    PubMed         Abstract available


    PLoS One

  22. SUN R, Guo S, Shuda Y, Chakka AB, et al
    Mitotic CDK1 and 4E-BP1 I: Loss of 4E-BP1 serine 82 phosphorylation promotes proliferative polycystic disease and lymphoma in aged or sublethally irradiated mice.
    PLoS One. 2023;18:e0282722.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: